Stop the Zombie Trial: The "Kill Switch" for Failed Experiments
The most expensive decision in drug development (or product experimentation) is not starting a trial. It is continuing a zombie trial. Imagine you are at the interim analysis of a Phase II study. You have enrolled 50 of 100 patients. You have spent $10 million. The data is... underwhelming. The